Is Zimmer Biomet Holdings, Inc. overvalued?

Zimmer Biomet Holdings, Inc. (ZBH) looks undervalued — trading about 133% below its fair value.

Undervalued

Price

$91.04

Fair value

$212.26

Current P/E

10.7

Normal P/E

25.0

Market cap

$17.61B

Dividend yield

1.1%

Return on equity

6.4%

Sector

Healthcare

Fair value compares ZBH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks